{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:42:59Z","timestamp":1767840179788,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06063-w","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T14:02:17Z","timestamp":1610805737000},"page":"715-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Scalp cooling in breast cancer patients treated with docetaxel\u2013cyclophosphamide: patient- and nurse-reported results"],"prefix":"10.1007","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-5457","authenticated-orcid":false,"given":"A.","family":"Coolbrandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"T\u2019Jonck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Blauwens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dejaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-9460","authenticated-orcid":false,"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-7963","authenticated-orcid":false,"given":"K.","family":"Punie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vancoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-7837","authenticated-orcid":false,"given":"H.","family":"Wildiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"issue":"10","key":"6063_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pon.3531","volume":"23","author":"EK Choi","year":"2014","unstructured":"Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH et al (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 23(10):1103\u20131110","journal-title":"Psychooncology"},{"issue":"5","key":"6063_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejon.2007.03.002","volume":"11","author":"H Frith","year":"2007","unstructured":"Frith H, Harcourt D, Fussell A (2007) Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer. Eur J Oncol Nurs 11(5):385\u2013391","journal-title":"Eur J Oncol Nurs"},{"issue":"5","key":"6063_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/1359105308090932","volume":"13","author":"D Harcourt","year":"2008","unstructured":"Harcourt D, Frith H (2008) Women\u2019s experiences of an altered appearance during chemotherapy: an indication of cancer status. J Health Psychol 13(5):597\u2013606","journal-title":"J Health Psychol"},{"issue":"9","key":"6063_CR4","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00520-016-3206-2","volume":"24","author":"J Shaw","year":"2016","unstructured":"Shaw J, Baylock B, O\u2019Reilly A, Winstanley J, Pugliano L, Andrews K, Boyle F (2016) Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Support Care Cancer 24(9):3813\u20133820","journal-title":"Support Care Cancer"},{"issue":"2","key":"6063_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","volume":"163","author":"HS Rugo","year":"2017","unstructured":"Rugo HS, Melin SA, Voigt J (2017) Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat 163(2):199\u2013205","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6063_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","volume":"317","author":"J Nangia","year":"2017","unstructured":"Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J et al (2017) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA 317(6):596\u2013605","journal-title":"JAMA"},{"issue":"6","key":"6063_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2016.21038","volume":"317","author":"HS Rugo","year":"2017","unstructured":"Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, Park G, Mitchel J, Bageman E, D\u2019Agostino RB Jr et al (2017) Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA 317(6):606\u2013614","journal-title":"JAMA"},{"issue":"1","key":"6063_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-018-4983-8","volume":"173","author":"K Smetanay","year":"2019","unstructured":"Smetanay K, Junio P, Feisst M, Seitz J, Hassel JC, Mayer L, Matthies LM, Schumann A, Hennigs A, Heil J et al (2019) COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat 173(1):135\u2013143","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6063_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4103\/apjon.apjon_4_19","volume":"6","author":"E Gianotti","year":"2019","unstructured":"Gianotti E, Razzini G, Bini M, Crivellaro C, Righi A, Darecchio S, Lui S, Basirico ML, Cocconi S, Cagossi K et al (2019) Scalp cooling in daily clinical practice for breast cancer patients undergoing curative chemotherapy: a multicenter interventional study. Asia Pac J Oncol Nurs 6(3):277\u2013282","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"4","key":"6063_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/0284186X.2012.658966","volume":"51","author":"CJ van den Hurk","year":"2012","unstructured":"van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients: results of the Dutch Scalp Cooling Registry. Acta Oncol 51(4):497\u2013504","journal-title":"Acta Oncol"},{"issue":"6","key":"6063_CR11","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00520-016-3084-7","volume":"24","author":"MM Komen","year":"2016","unstructured":"Komen MM, Breed WP, Smorenburg CH, van der Ploeg T, Goey SH, van der Hoeven JJ, Nortier JW, van den Hurk CJ (2016) Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 24(6):2735\u20132741","journal-title":"Support Care Cancer"},{"issue":"12","key":"6063_CR12","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00520-012-1465-0","volume":"20","author":"CJ van den Hurk","year":"2012","unstructured":"van den Hurk CJ, Breed WP, Nortier JW (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 20(12):3255\u20133260","journal-title":"Support Care Cancer"},{"issue":"2","key":"6063_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000501393","volume":"15","author":"FF Bitto","year":"2020","unstructured":"Bitto FF, Konig A, Phan-Brehm T, Vallbracht T, Koch JG, Schinkothe T, Wolfgarten M, Mahner S, Harbeck N, Wurstlein R (2020) EVA-scalp: evaluation of patient satisfaction with a scalp cooling device to prevent chemotherapy-induced alopecia in breast cancer patients. Breast Care 15(2):171\u2013177","journal-title":"Breast Care"},{"issue":"7","key":"6063_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","volume":"18","author":"MM Komen","year":"2013","unstructured":"Komen MM, Smorenburg CH, van den Hurk CJ, Nortier JW (2013) Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist 18(7):885\u2013891","journal-title":"Oncologist"},{"issue":"5","key":"6063_CR15","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00520-018-4432-6","volume":"27","author":"MMC Komen","year":"2019","unstructured":"Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Nieboer P, van der Hoeven JJM, Smorenburg CH (2019) Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer 27(5):1919\u20131925","journal-title":"Support Care Cancer"},{"issue":"4","key":"6063_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4103\/apjon.apjon_19_19","volume":"6","author":"C van den Hurk","year":"2019","unstructured":"van den Hurk C, Keizer-Heldens P, Raats I, Hoeijmakers K, Mols F (2019) Improving information provision on chemotherapy-induced alopecia and scalp cooling: a comprehensive approach including a website and web-based decision tool. Asia Pac J Oncol Nurs 6(4):336\u2013342","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"2","key":"6063_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","volume":"63","author":"B Tallon","year":"2010","unstructured":"Tallon B, Blanchard E, Goldberg LJ (2010) Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol 63(2):333\u2013336","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"6063_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","volume":"155","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Chan D, Sibaud V, Shapiro J, Fabbrocini G, Tosti A, Cho J, Goldfarb S, Modi S, Gajria D et al (2019) Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia. JAMA Dermatol 155(6):724\u2013728","journal-title":"JAMA Dermatol"},{"issue":"3","key":"6063_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","volume":"24","author":"D Kang","year":"2019","unstructured":"Kang D, Kim IR, Choi EK, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Lee HK, Park JH et al (2019) Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study. Oncologist 24(3):414\u2013420","journal-title":"Oncologist"},{"issue":"3","key":"6063_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","volume":"171","author":"M Martin","year":"2018","unstructured":"Martin M, de la Torre-Montero JC, Lopez-Tarruella S, Pinilla K, Casado A, Fernandez S, Jerez Y, Puente J, Palomero I, Gonzalez Del Val R et al (2018) Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat 171(3):627\u2013634","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06063-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-06063-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06063-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T00:05:20Z","timestamp":1617494720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-06063-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6063"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06063-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of UZ\/KU Leuven.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent to participate was obtained from all patients participating in the evaluation of patient-reported data. Written informed consent for publication of their details was obtained from all patients participating in the evaluation of patient-reported data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}